NCT03770130View on ClinicalTrials.gov

Dexmedetomidine and Liver Transplantation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions
Dexmedetomidine, Liver Transplantation, Allograft Function, Survival
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine, a selective α2-adrenoceptor agonist which is widely used as an adjuvant to general anaesthesia

DRUG

Saline

Saline, a kind of crystalloid widely used in clinical treatment

Trial Locations (1)

200127

Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03770130 - Dexmedetomidine and Liver Transplantation | Biotech Hunter | Biotech Hunter